General
Preferred name
sparteine
Synonyms
(-)-Lupinidine (sulfate pentahydrate) ()
(?)-Lupinidine ()
(-)-Sparteine sulfate salt ()
Lupinidine sulfate pentahydrate ()
Sparteine (-) ()
Sparteine Sulphate ()
(-)-Lupinidine ()
SPARTEIN ()
(-)-Sparteine ()
(-)-Sparteine sulfate pentahydrate ()
Sparteine sulfate pentahydrate ()
NSC-755834 ()
Sparteinum sulphuricum ()
SPARTEINE SULFATE ()
Esparteina ()
P&D ID
PD045705
CAS
90-39-1
6160-12-9
492-08-0
Tags
available
drug
Drug Status
experimental
approved
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
(-)-Sparteine sulfate pentahydrate is an alkaloid compound which could be used as in the treatment of antiarrhythmic by blocking sodium channel.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
11
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
41
Molecular Weight
234.21
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
0
cLogP
2.35
TPSA
6.48
Fraction CSP3
1.0
Chiral centers
4.0
Largest ring
6.0
QED
0.63
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
ATC
C01BA04
Toxicity type
reproductive
Solubility
DMSO: > 3.3 mg/mL
Target
Sodium Channel
Source data
